Dr. Rickels is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12-134 Smilow Center for Translational Research
3400 Civic Center Boulevard
Philadelphia, PA 19104Phone+1 215-746-0025Fax+1 215-898-5408
Education & Training
- Perelman School of Medicine at the University of Pennsylvania MS, Translational Research, 2002 - 2007
- University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2005
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 1999
Certifications & Licensure
- FL State Medical License 2022 - Present
- PA State Medical License 2000 - 2024
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Philip E. Cryer Lectureship Washington University in St. Louis, MO, 2022
- D. Walter Cohen, D.D.S. Lectureship in Diabetes Drexel University College of Medicine, Philadelphia, PA, 2017
- Best of JCEM 2016 The Endocrine Society, 2017
- Join now to see all
Clinical Trials
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass Start of enrollment: 2008 Oct 01
- Glucose Counterregulation in Long Standing Type 1 Diabetes Start of enrollment: 2011 Oct 01
- Beta-cell Response to Incretin Hormones in Cystic Fibrosis Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 267 citationsDiabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.Dana K. Andersen, Murray Korc, Gloria M. Petersen, Guido Eibl, Donghui Li
Diabetes. 2017-05-01 - 28 citationsBenefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.Kellee M Miller, Lauren G Kanapka, Michael R Rickels, Andrew J Ahmann, Grazia Aleppo
Diabetes Technology & Therapeutics. 2022-06-01 - 238 citationsSevere hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.Ruth S. Weinstock, Dongyuan Xing, David M. Maahs, Aaron W. Michels, Michael R. Rickels
The Journal of Clinical Endocrinology and Metabolism. 2013-06-12
Press Mentions
- Scientific Sessions Reviewed by ADA Podcast Co-Hosts! In This Special Episode, the Co-Hosts of DiabetesBio, Diabetes Care “On Air,” Diabetes Core Update, and Diabetes Day by Day Get Together to Discuss Highlights from the ADA’s 2024 Scientific SessiAugust 16th, 2024
- Islet Transplants in Type 1 Diabetes Durable up to 8 YearsOctober 19th, 2022
- New Islet Transplant Method Leads to Insulin IndependenceOctober 17th, 2022
- Join now to see all
Grant Support
- Restoring Awareness of Hypoglycemia in Type 1 DiabetesNIH/NIDDK2022–2027
- Radioimmunoassay and Biomarkers Core/Diabetes Research CenterNIH/NIDDK2015–2027
- Evaluation of the Entero-Insular (Incretin) Axis in Cystic FibrosisNIH/NIDDK2012–2025
- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients with New-Onset Type 1 DiabetesDompé Farmaceutici S.p.A.2021–2024
- A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D)NIH/NIDDK2019–2024
- Type 1 Diabetes and Exercise Initiative (TI-DEXI)Helmsley Charitable Trust2017–2024
- Glucose Counterregulation in Long Standing Type 1 DiabetesNIH/NIDDK2011–2023
- Supporting Individuals in Need with T1D Impacted by the COVID-19 PandemicHelmsley Charitable Trust2020–2021
- Glucose-Dependent Insulinotropic Polypeptide and CFTR Loss-of-FunctionCystic Fibrosis Foundation2019–2021
- Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe HypoglycemiaXeris Pharmaceuticals2018–2020
- Type 1 Diabetes Exchange Clinic NetworkHelmsley Charitable Trust2011–2020
- Integrated and Long-Term Analysis of Islet Product and Recipient Outcomes in the CIT Consortium TrialsJuvenile Diabetes Research Foundation International2019
- B-Lymphocyte Immunotherapy in Islet TransplantationNIH/NIDDK2004–2017
- Insulin and Incretin Secretion in Cystic FibrosisCystic Fibrosis Foundation2012–2015
- Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in HumansNIH/NIDDK2009–2014
- Center of Excellence for Regenerative MedicinePA Department of Health2008–2012
- Metabolic Consequences of Islet TransplantationJuvenile Diabetes Research Foundation International2002–2008
- Beta-Cell Function and Glucagon-Like Peptide-1 in Pancreas and Kidney TransplantationNIH/NIDDK2005–2007
- University of Pennsylvania School of Medicine Training Grant in Patient-Oriented ResearchNIH/NCRR2003–2006
- University of Pennsylvania School of Medicine Training Grant in Diabetes, Endocrine and Metabolic DiseasesNIH/NIDDK2002–2003
Committees
- Member, Steering Committee, Impaired Awareness of Hypoglycemia Consortium, NIDDK 2022 - Present
- Member, Steering Committee, A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus, Vertex Pharmaceuticals 2021 - Present
- Co-Chair (2017 - Present), Type 1 Diabetes EXercise Initiative (T1-DEXI), Jaeb Center for Health Research 2016 - Present
- Member, Advisory Committee, NIDDK Medical Student Research Program 2009 - Present
- Chair (2010 - Present), Publications and Presentations Committee, Collaborative Islet Transplant Registry, NIDDK 2009 - Present
- Member, Research Advisory Committee, Type 1 Diabetes Outcomes Program, JDRF International 2015 - 2017
- Member, Clinical and Integrative Diabetes and Obesity Study Section, NIH 2014 - 2018
- Chair (2018 - 2019), Data & Safety Monitoring Board, Restoring Insulin Secretion (RISE) Consortium, NIDDK 2012 - 2019
- Member, SBIR to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Toward an Artificial Pancreas SEP, NIDDK 2012 - 2014
- Vice-Chair (2015 - 2019), Type 1 Diabetes (T1D) Exchange Clinic Network and Registry, Jaeb Center for Health Research 2011 - 2020
- Member, Clinical Investigations Study Section, JDRF International 2006 - 2008
- Chair, Metabolic Study Subcommittee, Clinical Islet Transplantation Consortium, NIH 2004 - 2018
Professional Memberships
- Member, 2001 - Present
- Scientific Sessions Planning Committee, 2012 - 2014, 2020 - 2022; Associate Editor, Diabetes Care, 2022 - Present
- Endocrine SocietyEditorial Board, Journal of Clinical Endocrinology & Metabolism, 2009 - 2013; Associate Editor, Endocrine Reviews, 2015 - 2018
- International Pancreas and Islet Transplant AssociationElected Councilor, 2015 - 2021; Elected Treasurer, 2023 - Present
- International Hypoglycemia Study GroupMember, 2022 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: